Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Neuromuscular Disorder-Targeting Compound 1 is a compound used in the research of neuromuscular disorders, for example, symptoms of chronic fatigue syndrome and fibromyalgia syndrome.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
100 mg | Inquiry | Inquiry | |
500 mg | Inquiry | Inquiry |
Description | Neuromuscular Disorder-Targeting Compound 1 is a compound used in the research of neuromuscular disorders, for example, symptoms of chronic fatigue syndrome and fibromyalgia syndrome. |
Molecular Weight | 279.44 |
Formula | C15H25N3S |
CAS No. | 374538-23-5 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Neuromuscular Disorder-Targeting Compound 1 374538-23-5 Others Neuromuscular Disorder Targeting Compound 1 Neuromuscular DisorderTargeting Compound 1 inhibitor inhibit